Search results
Results from the WOW.Com Content Network
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
The Australian Health Protection Principal Committee (AHPPC) is the peak decision-making committee for public health emergency management and disease control in the Commonwealth of Australia. [ 1 ] [ 2 ] It is chaired by the Chief Medical Officer of the Australian Government and comprises the chief health officers of the states and territories .
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]
Australia's drug regulator has approved Pfizer's COVID-19 vaccine for use with 12 to 15-year-olds, Federal Health Minister Greg Hunt said on Friday, as the country fights an outbreak of the Delta ...
The COVID-19 pandemic in Australia was a part of the worldwide pandemic of the coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first confirmed case in Australia was identified on 25 January 2020, in Victoria , when a man who had returned from Wuhan , Hubei Province, China , tested positive ...
The National Drug Strategy (NDS) is the national drug regulation organization which maintains drug policy of the Australian Government. It began with its first framework in 1998 and has regularly formulated the Australian approach to drug education , treatment, rehabilitation , and prevention of substance abuse .
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. [4] As part of the Department of Health and Aged Care, the TGA regulates the safety, quality, efficacy and advertising in Australia of therapeutic goods (which comprise medicines, medical devices, biologicals and certain other therapeutic goods).
Data from the Australian Institute of Health and Welfare shows that out-of-pocket payments increased four-and-a-half times faster than government funding in 2014–15. [62] This has led to large numbers of patients skipping treatment or medicine. [63] Australian out-of-pocket health expenses are the third highest in the developed world. [62] [1]